Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,229 public trials 1,177 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

NCT04606472

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +43 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.

NCT05020457

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
View Trial Details
Active, Not Recruiting

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

NCT05485974

Conditions
Bronchial Neoplasms, Cancer, Cancer of Pancreas, +28 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas, California, United States
  • The Oncology Institute of Hope and Innovation Glendale, California, United States
  • The Oncology Institute of Hope and Innovation Long Beach, California, United States
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

NCT05163028

Conditions
Bronchial Neoplasms, Cancer, Cancer of Colon, +28 more
Locations
  • City of Hope Duarte, California, United States
  • California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • California Cancer Associates for Research and Excellence, Inc. (cCare) San Marcos, California, United States
View Trial Details
Active, Not Recruiting

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

NCT03289780

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Oncology Specialties, PC; Clearview Cancer Institute Huntsville, Alabama, United States
  • Lewis & Faye Manderson Cancer Center at DCH Regional Medical Center Tuscaloosa, Alabama, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • St. Bernards Cancer Center Hematology / Oncology Jonesboro, Arkansas, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial

NCT03306680

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • BC Cancer -Vancouver Island Vancouver, British Columbia, Canada
  • London Regional Cancer Program London, Ontario, Canada
  • Sunnybrook Odette Cancer Centre Toronto, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy

NCT02788461

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Kingston General Hospital Kingston, Ontario, Canada
  • London Regional Cancer Program London, Ontario, Canada
  • Stronach Regional Cancer Centre at Southlake Regional Health Centre Newmarket, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details

Related conditions